pharmaphorum May 20, 2022
A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app to support patients with atopic dermatitis, which will start rolling out in Europe and Japan later this year.
Sidekick specialises in developing gamified digital health apps. Its alliance with Pfizer has already led to the launch of a series of medication management and lifestyle software programmes aimed at five chronic diseases.
The new app addresses a skin disorder – commonly known as eczema – that affects up to 14% of adults worldwide and causes relentless itching that can seriously impact patients’ quality of life.
In the last few months, Pfizer has won approvals in the EU and US for JAK inhibitor Cibinqo...
Today's Sponsors
Today's Sponsor